Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis
Authors
Keywords
Metabolic disorders, Blood plasma, Fatty liver, Blood pressure, Cholesterol, Inflammation, Obesity, White blood cells
Journal
PLoS One
Volume 12, Issue 4, Pages e0174717
Publisher
Public Library of Science (PLoS)
Online
2017-04-05
DOI
10.1371/journal.pone.0174717
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression
- (2015) Hwan-Jin Hwang et al. BIOCHEMICAL PHARMACOLOGY
- Hepatokines: unlocking the multi-organ network in metabolic diseases
- (2015) Alison Iroz et al. DIABETOLOGIA
- Nonalcoholic Fatty Liver Disease
- (2015) Mary E. Rinella JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- LECT2 induces atherosclerotic inflammatory reaction via CD209 receptor-mediated JNK phosphorylation in human endothelial cells
- (2015) Hwan-Jin Hwang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Hepatokines as a Link between Obesity and Cardiovascular Diseases
- (2015) Hye Jin Yoo et al. Diabetes & Metabolism Journal
- Ectopic Fat, Insulin Resistance, and Nonalcoholic Fatty Liver Disease
- (2014) Christopher D. Byrne et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- LECT2 Functions as a Hepatokine That Links Obesity to Skeletal Muscle Insulin Resistance
- (2014) Fei Lan et al. DIABETES
- The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
- (2013) Gregory Gaich et al. Cell Metabolism
- The role of hepatokines in metabolism
- (2013) Norbert Stefan et al. Nature Reviews Endocrinology
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- The effects of caloric restriction on Fetuin-A and cardiovascular risk factors in rats and humans: a randomized controlled trial
- (2012) Kyung Mook Choi et al. CLINICAL ENDOCRINOLOGY
- LECT2 protects mice against bacterial sepsis by activating macrophages via the CD209a receptor
- (2012) Xin-Jiang Lu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
- (2011) G. Vernon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Combined Effect of Nonalcoholic Fatty Liver Disease and Impaired Fasting Glucose on the Development of Type 2 Diabetes: A 4-year retrospective longitudinal study
- (2011) J. C. Bae et al. DIABETES CARE
- The Clinical Utility of High-Sensitivity C-Reactive Protein in Cardiovascular Disease and the Potential Implication of JUPITER on Current Practice Guidelines
- (2008) S. Mora et al. CLINICAL CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now